ORCL

Oracle Corporation

$130.67

-6.37%
Oct 30, 2026
Bobby Quantitative Model
Oracle Corporation is a global enterprise software and infrastructure provider whose core franchises span relational database management systems, ERP and other cloud applications, and Oracle Cloud Infrastructure (OCI), which has become a key supplier of compute and networking capacity for large language model training and inference. Founded in 1977 and long the standard for high-volume online transaction processing at the world's largest enterprises, Oracle has repositioned itself from a legacy on-premise license vendor into a full-stack cloud platform challenger to hyperscalers, with a differentiated story built on database gravity, multi-cloud partnerships, and sovereign/enterprise-grade AI capacity. The current investor debate centers on whether Oracle's extraordinary cloud backlog — reported at roughly $664 billion — can be converted into revenue on schedule, with bulls pointing to 121% infrastructure growth and a top AI infrastructure positioning while skeptics focus on the enormous capital expenditure required, negative free cash flow, and margin dilution from consumption-based database and OCI mix. That tension between a record contracted backlog and a deeply negative cash conversion cycle has produced one of the most volatile large-cap narratives in technology, with the stock having swung from euphoric highs to a severe drawdown as AI monetization doubts (echoed by peer commentary on AI spending without clear returns) have weighed on sentiment.

People also watch

Microsoft

Microsoft

MSFT

Analysis
Palantir Technologies

Palantir Technologies

PLTR

Analysis
Palo Alto Networks

Palo Alto Networks

PANW

Analysis
CrowdStrike

CrowdStrike

CRWD

Analysis
Fortinet

Fortinet

FTNT

Analysis

BobbyInvestment Opinion: Should I buy ORCL Today?

Rating: Hold. Oracle's core thesis is a high-stakes bet on converting a $664 billion cloud backlog into revenue, but the negative free cash flow (-$28.72 billion TTM) and margin compression (gross margin down to 60.03%) create substantial execution risk. The analyst consensus is 'buy' with an average target of $236.54 (+87.5% upside), but the stock's 54.95% one-year decline and technical breakdown suggest the market is skeptical. We recommend a Hold until there is clearer evidence of backlog conversion and cash flow inflection.

The supporting evidence is mixed. On the positive side, revenue growth is exceptional at 29.61% YoY, EPS grew to $1.58 from $1.04, and the forward PE of 11.48x is undemanding if consensus EPS of $27.84 is achieved. The PEG ratio of 1.26 suggests the growth-adjusted valuation is reasonable. However, the PS ratio of 10.60x and EV/EBITDA of 25.06x are premium multiples that assume flawless execution, while the negative FCF and 3.67x debt-to-equity justify a discount. The wide analyst target range ($110-$400) signals high uncertainty.

The biggest risks are: (1) backlog conversion delays or cancellations, (2) further margin erosion if OCI mix increases, and (3) financing risk if cash flow remains negative. The rating would upgrade to Buy if free cash flow turns positive or if the stock breaks above $156 (the August-September resistance) with improving fundamentals. It would downgrade to Sell if gross margin falls below 55% or if revenue growth decelerates below 20%. Relative to its own history, the PS multiple has de-rated ~75% from 42.81x in Q1 FY26 to 10.60x today, suggesting the stock is near the low end of its valuation band, but the negative FCF warrants caution. Fairly valued to slightly undervalued on forward earnings, but overvalued on current cash flow.

Sign up to view all

ORCL 12-Month Price Forecast

Oracle presents a high-risk, high-reward opportunity. The bull case is supported by explosive revenue growth, a massive backlog, and a low forward PE, but the bear case is equally compelling given negative free cash flow, margin compression, and high leverage. The stock's technical downtrend and relative weakness suggest the market is pricing in significant execution risk. We are neutral with medium confidence because the outcome hinges on backlog conversion and cash flow inflection, which are difficult to predict. An upgrade to bullish would require evidence of positive free cash flow and margin stabilization; a downgrade to bearish would follow a break below $114.50 or further margin deterioration.

Historical Price
Current Price $130.67
Average Target $175.00
High Target $400.00
Low Target $110.00

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Oracle Corporation's 12-month outlook, with a consensus price target around $235.80 and implied upside of +80.5% versus the current price.

Average Target

$235.80

0 analysts

Implied Upside

+80.5%

vs. current price

Analyst Count

—

covering this stock

Price Range

$110 - $400

Analyst target range

Coverage is broad and overwhelmingly constructive: 41 analysts cover Oracle with a consensus recommendation of "buy" (mean rating 1.58 on a 1-5 scale where 1 is strong buy). The average target price of $236.54 implies roughly +87.5% upside from the current $126.16 — an unusually large gap that reflects either significant analyst conviction in the backlog conversion story or stale targets that have not been marked down during the recent selloff. Recent institutional actions skew positive, with Buy/Outperform reiterations from Stifel, BMO, Guggenheim, UBS, TD Cowen, DA Davidson, Argus, and Freedom Broker in mid-September, alongside Equal Weight/Sector Perform holds from Stephens and RBC.

The target range is extraordinarily wide — from a low of $110.00 (about -12.8% downside) to a high of $400.00 (roughly +217% upside) — signaling very high uncertainty rather than tight conviction. The high target assumes successful conversion of the $664 billion backlog, sustained 100%+ infrastructure growth, and multiple expansion as Oracle is re-rated as a premier AI infrastructure platform; the low target prices in margin compression, capex overruns, and the risk that AI demand proves less durable than the backlog suggests. The wide dispersion, combined with the stock trading near its 52-week low and the average target sitting far above the current price, is a classic setup for either a violent mean-reversion rally or further target cuts — investors should treat the consensus average with caution until price action confirms a bottom.

Drowning in data?

Find the real signal!

Bulls vs Bears: ORCL Investment Factors

The bull case rests on Oracle's exceptional 29.61% revenue growth, a $664 billion cloud backlog, and a forward PE of 11.5x that implies significant upside if execution continues. The bear case centers on deeply negative free cash flow (-$28.72 billion TTM), margin compression (gross margin down to 60.03% from 67.28%), and high leverage (3.67x debt-to-equity), all of which raise questions about the sustainability of the AI buildout. Currently, the bear evidence appears stronger given the stock's 54.95% one-year decline, technical breakdown, and negative cash conversion, but the analyst consensus (buy, $236.54 target) and backlog provide a powerful counterweight. The single most important tension is whether the $664 billion backlog converts to revenue on schedule without further margin erosion; if it does, the stock is dramatically undervalued, but if conversion slips or margins compress further, the downside could be severe.

Bullish

  • Explosive revenue acceleration: Q1 FY27 revenue grew 29.61% YoY to $19.345 billion, up from $14.926 billion a year earlier, with sequential acceleration from $16.058B to $17.190B to $19.184B to $19.345B over the last four quarters. This is exceptional growth for a company of Oracle's scale and directly supports the bull case that AI-driven demand is converting into reported revenue.
  • Massive $664B cloud backlog: Oracle's reported cloud backlog of roughly $664 billion represents contracted future revenue that, if converted on schedule, would sustain high growth for years. The backlog is underpinned by 121% infrastructure growth, positioning Oracle as a top AI infrastructure play according to recent coverage.
  • Forward PE of 11.5x looks cheap: The forward PE of 11.48x is less than one-third of the trailing PE of 41.78x, implying the market expects a dramatic earnings step-up to consensus EPS of $27.84. If backlog conversion proceeds and margins hold, the stock is priced for significant multiple expansion.
  • Analyst consensus strongly bullish: 41 analysts rate ORCL a 'buy' with a mean rating of 1.58 (1=strong buy) and an average target price of $236.54, implying +87.5% upside from $126.16. Recent reiterations from Stifel, BMO, Guggenheim, UBS, TD Cowen, DA Davidson, Argus, and Freedom Broker confirm broad institutional conviction.

Bearish

  • Deeply negative free cash flow: TTM free cash flow is -$28.72 billion, driven by $28.499 billion of capex in Q1 FY27 alone against $23.103 billion of operating cash flow. Oracle is dependent on external financing ($19.909 billion of stock issued in the quarter) until capex normalizes, a major risk if capital markets tighten.
  • Severe margin compression: Gross margin fell to 60.03% in Q1 FY27 from 65.18% in Q4 FY26 and 67.28% in Q1 FY26, reflecting the heavier mix of lower-margin OCI infrastructure and consumption-based database revenue. If this trend continues toward the mid-50s, the earnings power implied by consensus becomes harder to defend.
  • High leverage and interest burden: Debt-to-equity stands at 3.67x (total debt to capitalization of 78.6%), and interest expense of $1.428 billion consumed a meaningful share of $5.607 billion pre-tax income in Q1 FY27. ROE of 40.2% is flattered by leverage, while ROA of 6.36% better reflects the capital intensity.
  • Technical downtrend and relative weakness: The stock is down 54.95% over the trailing year and 35.54% YTD, with relative strength of -68.08% vs. SPY over one year. At $126.16, it sits just 10.2% above the 52-week low of $114.50, signaling persistent distribution and vulnerability to further downside.

ORCL Technical Analysis

Oracle is in a pronounced, sustained downtrend: the stock is down 54.95% over the trailing year and 35.54% year-to-date, a stark reversal from the AI-driven euphoria that earlier pushed shares toward the 52-week high of $287.19. At the current price of $126.16, the stock sits just 10.2% above its 52-week low of $114.50, meaning it is trading at roughly 10% of its 52-week range — a positioning that signals persistent distribution and momentum breakdown rather than a healthy pullback, and one that leaves the stock vulnerable to further downside until a base forms. The relative strength figures confirm the damage: -68.08% versus SPY over one year and -46.99% YTD, an extreme underperformance gap for a mega-cap.

Short-term momentum is mixed but net negative. The 1-month change of -12.73% shows renewed selling pressure into late October, while the 3-month change of +9.71% and relative strength of +6.86% over that window indicate a brief summer-to-fall stabilization that has since rolled over. The 6-month change of -27.19% and relative strength of -33.64% confirm the intermediate trend remains firmly down, and the recent sequence of lower highs — from the August rally peak near $156 to the October slide back toward $125 — suggests the bounce off the July low of $114.99 has failed to establish a higher-low structure. The latest session's modest +0.49% gain on 19.2 million shares is not enough to signal capitulation or accumulation.

Key technical levels are well defined: support sits at the 52-week low of $114.50 (with the July closing low of $114.99 as the practical floor), while resistance is layered at the $140-$156 zone where the August-September rallies repeatedly stalled, and the 52-week high of $287.19 is a distant reference. A decisive break below $114.50 would confirm a fresh leg lower and likely trigger momentum-driven selling, whereas reclaiming $156 would be the first evidence of a trend change. With a beta of 1.77, Oracle is roughly 77% more volatile than the S&P 500, and a max drawdown of -64.96% underscores the severity of the current de-rating — position sizing and stop discipline are critical given this volatility profile.

Beta

1.77

1.77x market volatility

Max Drawdown

-63.3%

Largest decline past year

52-Week Range

$115-$266

Price range past year

Annual Return

-49.1%

Cumulative gain past year

PeriodORCL ReturnS&P 500
1m-4.8%-0.9%
3m+0.6%+1.2%
6m-24.0%+4.9%
1y-49.1%+11.2%
ytd-33.2%+10.8%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

ORCL Fundamental Analysis

Revenue is growing at an exceptional pace for a company of Oracle's scale: fiscal Q1 2027 (quarter ended August 31, 2026) revenue reached $19.345 billion, up 29.61% year-over-year from $14.926 billion, and the sequential progression from $16.058 billion (Q2 FY26) to $17.190 billion (Q3) to $19.184 billion (Q4) to $19.345 billion shows a clear acceleration rather than deceleration. The Cloud and License business is the engine, contributing $17.157 billion of the quarter's revenue, versus $774 million from hardware and $1.414 billion from services — meaning cloud and license is roughly 89% of the top line and the sole driver of the growth story. This trajectory, underpinned by the reported $664 billion cloud backlog, supports the bull case that Oracle is converting contracted AI demand into reported revenue, though the concentration in a single segment raises execution risk if backlog conversion slips.

Profitability remains solid but is being diluted by the growth mix. Q1 FY27 net income was $4.76 billion on a 24.61% net margin, with gross margin of 60.03% — down from 65.18% in Q4 FY26 and 67.28% in Q1 FY26 — reflecting the heavier weight of lower-margin OCI infrastructure and consumption-based database revenue. Operating income of $6.728 billion (34.78% operating margin) and EBITDA of $10.393 billion (53.72% EBITDA margin) show the core business is still highly profitable, and EPS of $1.58 grew from $1.04 a year earlier. The margin compression is the key watch item: if gross margin continues sliding toward the mid-50s, the earnings power implied by consensus estimates becomes harder to defend.

Balance sheet and cash flow are the pressure point. Debt-to-equity stands at 3.67x (total debt to capitalization of 78.6%), interest expense of $1.428 billion in the quarter consumed a meaningful share of the $5.607 billion pre-tax income, and free cash flow TTM is deeply negative at -$28.72 billion, driven by capital expenditure of $28.499 billion in Q1 FY27 alone against operating cash flow of $23.103 billion. The company is funding its AI buildout with debt and equity issuance — $19.909 billion of common stock issued in the quarter — and its current ratio of 1.115 and cash balance of $38.934 billion provide near-term liquidity, but the negative FCF profile means Oracle is dependent on external financing until capex normalizes. ROE of 40.2% looks strong but is flattered by leverage, while ROA of 6.36% better reflects the capital intensity of the current investment cycle.

Quarterly Revenue

$19.3B

2026-08

Revenue YoY Growth

+29.6%

YoY Comparison

Gross Margin

60.0%

Latest Quarter

Free Cash Flow

$-28.7B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Cloud And License Business
Hardware Business
Services Business

Open an Account, get $2 TSLA now!

Valuation Analysis: Is ORCL Overvalued?

Because Oracle is profitable (net income of $4.76 billion in the latest quarter), the PE ratio is the appropriate primary metric. The trailing PE of 41.78x compares with a forward PE of just 11.48x — an unusually wide gap that implies the market expects a dramatic earnings step-up, consistent with consensus EPS estimates of $27.84 for the forward period versus the current run-rate. That gap is the crux of the valuation debate: the forward multiple looks cheap only if the backlog converts on schedule and margins hold, while the trailing multiple reflects a stock that has already de-rated sharply from its highs.

Against its own sector, Oracle's multiples are mixed. The PS ratio of 10.60x and EV/Sales of 7.20x are elevated for a company with 60% gross margins, and the EV/EBITDA of 25.06x and PCF of 22.33x sit at premium levels that assume continued high-teens-plus growth. The PEG ratio of 1.26 is the most reasonable-looking metric in the set, suggesting the growth-adjusted multiple is not stretched — but that depends entirely on the reliability of the forward EPS estimate. Peer industry averages were not provided in the valuation data, so a precise premium/discount spread cannot be quantified; qualitatively, Oracle's 10.6x sales multiple is well above the software-infrastructure norm and prices in sustained AI-driven growth.

Historically, Oracle's valuation has compressed dramatically. The PS ratio was 42.81x in Q1 FY26 and 37.23x in Q4 FY26, versus 10.60x today — a roughly 75% de-rating in the sales multiple — while the PE ratio has ranged from 23.4x to 54.4x over the past year and now sits at 41.78x trailing. The stock is therefore near the low end of its own recent valuation band on a sales basis but mid-range on earnings, which suggests the market has already priced in significant execution risk; the question is whether the forward earnings estimate of $27.84 is achievable given negative free cash flow and margin compression. A PEG of 1.26 and forward PE of 11.5x imply the stock is cheap if the growth materializes, but the negative FCF and 3.67x debt-to-equity justify a discount until cash generation inflects.

PE

41.8x

Latest Quarter

vs. Historical

High-End

5-Year PE Range 15x~42x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

25.1x

Enterprise Value Multiple

Investment Risk Disclosure

Oracle faces significant financial and operational risks. The most acute is the deeply negative free cash flow of -$28.72 billion TTM, driven by $28.499 billion of capex in Q1 FY27 alone, which forces reliance on external financing ($19.909 billion of stock issued in the quarter). Debt-to-equity of 3.67x and interest expense of $1.428 billion in Q1 FY27 consume a meaningful portion of pre-tax income ($5.607 billion), while gross margin has compressed from 67.28% to 60.03% year-over-year due to the lower-margin OCI mix. Revenue concentration is extreme: cloud and license contributed $17.157 billion of $19.345 billion (89% of revenue), so any slowdown in that segment would be highly damaging. Additionally, the company's growth requires continued capex, and if backlog conversion slips, the negative cash cycle could persist longer than expected.

Market and competitive risks are elevated. The stock trades at a premium PS of 10.60x and EV/EBITDA of 25.06x, which assumes sustained high growth; any deceleration could trigger multiple compression. Competition from hyperscalers (AWS, Azure, Google Cloud) and AI-native neoclouds (e.g., CoreWeave) is intense, and recent warnings from IBM's CEO about AI spending without clear returns, plus OpenAI's lower-than-expected revenue, highlight monetization uncertainty. The beta of 1.77 means Oracle is 77% more volatile than the S&P 500, amplifying market swings. Regulatory headwinds, such as potential antitrust scrutiny of cloud bundling, and macro sensitivity (rising bond yields pressuring growth stocks) add further risk. The recent 15% drop in CoreWeave on Gartner's neocloud warning underscores sector-wide overcapacity concerns.

The worst-case scenario involves a perfect storm: backlog conversion delays, continued margin compression, and a financing crunch. If AI demand proves less durable and capex remains elevated, free cash flow could stay negative, forcing dilutive equity raises or debt at higher rates. The stock could retest its 52-week low of $114.50 (a -9.2% decline from $126.16) and potentially break below toward the analyst low target of $110.00 (-12.8%). Given the max drawdown of -64.96% over the past year, a severe de-rating to $80-$90 (a -29% to -36% decline) is plausible if sentiment worsens. Investors could lose 13-36% from current levels in this adverse scenario.

FAQ

The key risks are: (1) Financial: negative free cash flow of -$28.72B TTM and debt-to-equity of 3.67x, which could force dilutive financing. (2) Operational: gross margin compression from 67.28% to 60.03% due to lower-margin OCI mix, and revenue concentration (89% from cloud and license). (3) Market: high beta of 1.77 and a 54.95% one-year decline, with relative strength of -68.08% vs. SPY. (4) Competitive: intense pressure from hyperscalers and AI monetization doubts, as highlighted by IBM's CEO warning. Ranked by severity: financial and operational risks are most immediate, followed by market and competitive risks.

Our 12-month forecast has three scenarios: Bull (25% probability) with a target range of $236-$400, assuming successful backlog conversion and margin stabilization; Base (50%) with a range of $150-$200, assuming steady execution and gradual FCF improvement; Bear (25%) with a range of $110-$130, assuming delays and margin compression. The base case is most likely, hinging on revenue growth of 20-25% and gross margin stabilizing around 58-60%. The wide range reflects high uncertainty, and the stock could remain volatile.

ORCL appears undervalued on forward earnings but overvalued on current cash flow. The forward PE of 11.48x is low relative to the trailing PE of 41.78x, implying the market expects a significant earnings increase. The PS ratio of 10.60x is elevated for a company with 60% gross margins, but it has de-rated ~75% from 42.81x in Q1 FY26. The PEG ratio of 1.26 suggests a fair growth-adjusted valuation. However, the negative free cash flow and high leverage justify a discount. The market is pricing in successful backlog conversion; if that falters, the stock could be overvalued.

ORCL is a high-risk, high-reward buy candidate for investors with a long time horizon and tolerance for volatility. The stock trades at $126.16, down 54.95% over the past year, and offers 87.5% upside to the analyst average target of $236.54. However, the company has negative free cash flow of -$28.72 billion TTM and a debt-to-equity of 3.67x, which are significant risks. The biggest downside risk is a break below the 52-week low of $114.50, which could lead to further losses. For risk-averse investors, it is better to wait for evidence of positive free cash flow and margin stabilization before buying.

ORCL is more suitable for long-term investment (minimum 3-5 years) given its growth stage, high volatility (beta 1.77), and the time needed for backlog conversion and cash flow inflection. Short-term trading is risky due to the pronounced downtrend and potential for further downside. The dividend yield of 0.81% is low, so income is not a reason to hold. Earnings visibility is moderate, with analyst estimates for EPS of $27.84, but execution risk is high. A suggested minimum holding period is 3 years to allow the AI infrastructure buildout to mature.